.png){kind=icon}
Return
Quo vadis polyplex?
.png){kind=icon}
PRE
AI
DOI：10.1016/j.jconrel.2014.06.009.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Polymeric siRNA delivery has been an important field for the Journal of Controlled Release since the early 2000s. With currently about 1600 publications on this topic that can be found in Scopus, we have to ask ourselves why the clinical translation has been so slow. In this review we address the importance of in vivo studies, the problem of biocompatibility of the carrier systems, intracellular entrapment and endosomal release, as well as stability issues in the presence of serum. Most of all, we ask the question: Quo vadis? Where do polymeric carriers go inside the cell and inside the body and how does this affect repeated administration? We show that the gap of knowledge on polymer biodistribution and excretion has not been closed yet and needs to be addressed to develop safe RNAi therapeutics. (C) 2014 Elsevier B.V. All rights reserved.
Keywords:
siRNA
Biodistribution
Nanocarrier
Polymer
Biodegradation
Stability
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
11.5
Papers:
1.5W
Citations:
7.4W
Organization
Cited Papers
ShareSaveShareSaveA biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.png)
BIOMATERIALS
BIOMATERIALSIF12.9
PREAI
ShareSave
ShareSaveIn vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymersBIOMATERIALS
BIOMATERIALSIF12.9
PREAI
ShareSaveSupramolecular gene delivery vectors showing enhanced transgene expression and good biocompatibility
PREAI
ShareSave
View more